Axel Schambach

21.9k total citations · 3 hit papers
332 papers, 13.5k citations indexed

About

Axel Schambach is a scholar working on Molecular Biology, Genetics and Oncology. According to data from OpenAlex, Axel Schambach has authored 332 papers receiving a total of 13.5k indexed citations (citations by other indexed papers that have themselves been cited), including 231 papers in Molecular Biology, 169 papers in Genetics and 100 papers in Oncology. Recurrent topics in Axel Schambach's work include Virus-based gene therapy research (157 papers), CRISPR and Genetic Engineering (133 papers) and RNA Interference and Gene Delivery (87 papers). Axel Schambach is often cited by papers focused on Virus-based gene therapy research (157 papers), CRISPR and Genetic Engineering (133 papers) and RNA Interference and Gene Delivery (87 papers). Axel Schambach collaborates with scholars based in Germany, United States and United Kingdom. Axel Schambach's co-authors include Christopher Baum, Christopher Baum, Melanie Galla, Tobias Maetzig, Michael Morgan, Ute Modlich, Daniela Zychlinski, Jens Bohne, Michael Rothe and Hildegard Büning and has published in prestigious journals such as Cell, Proceedings of the National Academy of Sciences and The Lancet.

In The Last Decade

Axel Schambach

317 papers receiving 13.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

LEF-1 is crucial for neutrophil granulocytopoiesis and its expression is severely reduced in congenital neutropenia

2006 964 citations Axel Schambach, Matthias Eder et al. profile →
Skin tissue generation by laser cell printing

2012 430 citations Axel Schambach et al. profile →
Refined sgRNA efficacy prediction improves large- and small-scale CRISPR–Cas9 applications

2017 196 citations Maurice Labuhn, Felix F. Adams et al. Nucleic Acids Research profile →

Peers

Countries citing papers authored by Axel Schambach

Since Specialization

Citations

This map shows the geographic impact of Axel Schambach's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Axel Schambach with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Axel Schambach more than expected).

Fields of papers citing papers by Axel Schambach

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Axel Schambach. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Axel Schambach. The network helps show where Axel Schambach may publish in the future.

Co-authorship network of co-authors of Axel Schambach

This figure shows the co-authorship network connecting the top 25 collaborators of Axel Schambach. A scholar is included among the top collaborators of Axel Schambach based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Axel Schambach. Axel Schambach is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Somatic hypermutation shapes the viral escape profile of SARS-CoV-2 neutralising antibodies 2025 ·EBioMedicine ·(unknown), (unknown), Mariana González-Hernández, (unknown), Md. Abdus Salam, (unknown), (unknown), (unknown), Yannic C. Bartsch, Axel Schambach, Gert Zimmer, Wolfgang Baumgärtner, (unknown), Ulrich Kalinke	0
2	Combination of targeted pharmacotherapy and immunotherapy with anti‐CD19 CAR NK cells in acute lymphoblastic leukemia 2025 ·HemaSphere ·(unknown), (unknown), Lisa Fleischer, (unknown), Ruth Esser, Steven R. Talbot, Axel Schambach, Ulrike Koehl, Olaf Heidenreich, Matthias Eder, Michaela Scherr	0
3	Blood-generating heart-forming organoids recapitulate co-development of the human haematopoietic system and the embryonic heart 2024 ·Nature Cell Biology ·(unknown), (unknown), (unknown), (unknown), Liam Wilson, Annika Franke, Jana Teske, (unknown), Jeanne de la Roche, Martin Fischer, (unknown), Axel Schambach, Lika Drakhlis, Robert Zweigerdt	9
4	The caspase-inhibitor Emricasan efficiently counteracts cisplatin- and neomycin-induced cytotoxicity in cochlear cells 2024 ·Journal of Molecular Medicine ·(unknown), Juliane W. Schott, (unknown), Athanasia Warnecke, Michael R. A. Morgan, Melanie Galla, Axel Schambach	3
5	Tumor Organoid and Spheroid Models for Cervical Cancer 2023 ·Cancers ·(unknown), (unknown), (unknown), Rüdiger Klapdor, Michael Morgan, Axel Schambach	14
6	Third-generation lentiviral gene therapy rescues function in a mouse model of Usher 1B 2023 ·Molecular Therapy ·Juliane W. Schott, Peixin Huang, Michael Morgan, (unknown), (unknown), (unknown), Hildegard Büning, Athanasia Warnecke, Axel Schambach, Hinrich Staecker	10
7	CAR-NK Cells Targeting HER1 (EGFR) Show Efficient Anti-Tumor Activity against Head and Neck Squamous Cell Carcinoma (HNSCC) 2023 ·Cancers ·(unknown), (unknown), (unknown), Katharina Zimmermann, (unknown), Doris Steinemann, Stephan Kloeß, Ulrike Koehl, (unknown), (unknown), Dirk Schaudien, Lavinia Neubert, Jan C. Kamp, Mark Kuehnel, Athanasia Warnecke, Axel Schambach, Michael Morgan	13
8	CD24 targeting with NK‐CAR immunotherapy in testis, prostate, renal and (luminal‐type) bladder cancer and identification of direct CD24 interaction partners 2023 ·FEBS Journal ·(unknown), David Thomas, Margaretha A. Skowron, Felix Bremmer, Markus Eckstein, Anja Stefanski, Marc D. Drießen, (unknown), Kai Stühler, Peter Altevogt, Dan Theodorescu, Rüdiger Klapdor, Axel Schambach, Daniel Nettersheim	9
9	Selection and validation of siRNAs preventing uptake and replication of SARS-CoV-2 2023 ·Pneumologie ·(unknown), Maik Friedrich, Gerd P. Pfeifer, (unknown), (unknown), Gustavo R. Makert, Axel Schambach, Thomas Grünwald, Ulrike Köhl, (unknown)	0
10	Improved alpharetrovirus-based Gag.MS2 particles for efficient and transient delivery of CRISPR-Cas9 into target cells 2022 ·Molecular Therapy — Nucleic Acids ·(unknown), (unknown), (unknown), (unknown), Denise Klatt, Dirk Hoffmann, (unknown), (unknown), (unknown), (unknown), Julia D. Suerth, Florian W. R. Vondran, Johann Meyer, Michael Morgan, Axel Schambach, Melanie Galla	13
11	Risk assessment in gene therapy and somatic genome-editing: An expert interview study 2022 ·(unknown), Dirk Hoffmann, (unknown), Marcel Mertz, Axel Schambach, Daniel Strech	3
12	Airway basal cells show a dedifferentiated KRT17highPhenotype and promote fibrosis in idiopathic pulmonary fibrosis 2022 ·Nature Communications ·(unknown), Jonas C. Schupp, (unknown), (unknown), (unknown), Gian Kayser, Peggy Engelhard, Taylor Adams, Robert Zweigerdt, Henning Kempf, Stefan Lienenklaus, Wiebke Garrels, Irina Nazarenko, Danny Jonigk, Małgorzata Wygrecka, Denise Klatt, Axel Schambach, Naftali Kaminski, Antje Prasse	61
13	Polarization of human iPSC-derived macrophages directs their immunological response to secondary pro-inflammatory stimuli 2022 ·(unknown), (unknown), (unknown), Miriam Hetzel, (unknown), (unknown), Adrian Schwarzer, Gesine Hansen, Axel Schambach, Nico Lachmann, Mania Ackermann	2
14	Myeloid-Derived Growth Factor Protects Against Pressure Overload–Induced Heart Failure by Preserving Sarco/Endoplasmic Reticulum Ca ²⁺ -ATPase Expression in Cardiomyocytes 2021 ·Circulation ·Mortimer Korf‐Klingebiel, Marc R. Reboll, Felix Polten, Natalie Weber, (unknown), Xuekun Wu, Marinos Kallikourdis, Paolo Kunderfranco, Gianluigi Condorelli, Evangelos Giannitsis, Olga Kustikova, Axel Schambach, Andreas Pich, Julian D. Widder, Johann Bauersachs, Joop van den Heuvel, Theresia Kraft, (unknown), Kai C. Wollert	40
15	Effective drug treatment identified by in vivo screening in a transplantable patient-derived xenograft model of chronic myelomonocytic leukemia 2020 ·Leukemia ·Arnold Kloos, (unknown), (unknown), Razif Gabdoulline, (unknown), Nidhi Jyotsana, (unknown), Renate Schottmann, Michaela Scherr, Charu Gupta, Felix F. Adams, Adrian Schwarzer, Dirk Heckl, Axel Schambach, Suzan Imren, R. Keith Humphries, Arnold Ganser, Felicitas Thol, Michael Heuser	9
16	Rapid and efficient generation of oligodendrocytes from human induced pluripotent stem cells using transcription factors 2017 ·Proceedings of the National Academy of Sciences ·Marc Ehrlich, Sabah Mozafari, Michael Glatza, Laura Starost, Sergiy Velychko, (unknown), (unknown), Axel Schambach, Kee-Pyo Kim, Corinne Bachelin, Antoine Marteyn, Gunnar Hargus, Radia Marie Johnson, Jack P. Antel, Jared Sterneckert, Holm Zaehres, Hans R. Schöler, Anne Baron‐Van Evercooren, Tanja Kuhlmann	190
17	Refined sgRNA efficacy prediction improves large- and small-scale CRISPR–Cas9 applications breakdown → 2017 ·Nucleic Acids Research ·Maurice Labuhn, Felix F. Adams, Michelle Ng, Sabine Knoess, Axel Schambach, Emmanuelle Charpentier, Adrian Schwarzer, Juan L. Mateo, Jan‐Henning Klusmann, Dirk Heckl	196
18	Induced Pluripotent Stem Cells Generated from Adult Bone Marrow–Derived Cells of the Nonhuman Primate (Callithrix jacchus) Using a Novel Quad-Cistronic and Excisable Lentiviral Vector 2012 ·Cellular Reprogramming ·(unknown), Kathrin Hemmer, Inga Bernemann, Gudrun Göhring, Olena Pogozhykh, Constança Figueiredo, Silke Glage, Axel Schambach, Jens C. Schwamborn, Rainer Blasczyk, Thomas Müller	31
19	Induction of Pluripotent Stem Cells from a Cynomolgus Monkey Using a Polycistronic Simian Immunodeficiency Virus–Based Vector, Differentiation Toward Functional Cardiomyocytes, and Generation of Stably Expressing Reporter Lines 2012 ·Cellular Reprogramming ·Stephanie Wunderlich, Alexandra Haase, Sylvia Merkert, (unknown), Kristin Schwanke, Axel Schambach, Silke Glage, Gudrun Göhring, Eliza Curnow, Ulrich Martin	16
20	Polyclonal fluctuation of lentiviral vector–transduced and expanded murine hematopoietic stem cells 2011 ·Blood ·Tobias Maetzig, Martijn H. Brugman, Stefan Bartels, Niels Heinz, Olga Kustikova, Ute Modlich, Zhixiong Li, Melanie Galla, Bernhard Schiedlmeier, Axel Schambach, Christopher Baum	46

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact